However, as of March 2026, Hers claims it has shifted its focus to FDA-approved weight-loss treatments, limiting compounded semaglutide to medical necessity
Focus instead on individual compounds with actual evidence: Most evidence-based options: Berberine (1,000-1,500mg daily): For metabolic syndrome support, insulin sensitivity improvement, modest glucose and lipid benefits Fiber supplements (25-38g daily total from food and supplements): For satiety, gut health, and transient GLP-1 increases Product selection criteria: Transparent ingredient amounts (no proprietary blends) Research-supported dosing Third-party testing certifications (USP, NSF, Informed Choice) Realistic marketing without pharmaceutical comparisons Rather than choosing based on GLP-1 booster labels, select evidence-based compounds appropriate to your specific metabolic needs
IGF-1 LR3 bypasses that entire regulatory sequence and acts directly on tissue-level IGF-1 receptors, which is why research describes its signaling onset as faster and more direct than secretagogue-based approaches, though also more potent at the receptor level
Cost: Insurance coverage varies widely
.png)
